Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

Chapter 22

Pharmacology for NursesChapter 22

Case Study

1.
a. Nitroglycerin dilates coronary arteries, which increases oxygen delivery to the heart tissue, thereby reducing chest pain.
2.
c. A history of asthma is a contraindication to taking aspirin.

Review Questions

1.
b. Morphine is a potent opioid agonist and can cause respiratory depression and failure. It is very important to monitor the client frequently (reassess at least every 5–10 minutes) when using morphine to control chest pain.
2.
c. Nitroglycerin is a vasodilator, and vasodilation causes the blood pressure to drop.
3.
a. Adenosine has a very short half-life and should be administered as a rapid IV bolus directly into a vein over 1–2 seconds, followed by a rapid saline flush.
4.
c. The nurse should ask whether the client is taking any medications for erectile dysfunction because the use of nitroglycerin is contraindicated in clients who are taking a phosphodiesterase inhibitor such as tadalafil or sildenafil.
5.
a. Stable angina occurs during exercise or exertion and improves with rest. Stable angina presents when the heart needs more oxygen but the supply of oxygen is restricted. Once the heart does not need increased oxygen, the angina subsides.
6.
b. The ordered dose of diltiazem is 0.25 mg/kg, and 176 l b ÷ 2.2 k g = 80 k g , so 0.25 m g / k g × 80 k g = 20 m g .
7.
a. The therapeutic effects of epinephrine include bronchodilation, increased heart rate, and increased blood pressure.
8.
b. Dopamine causes vasospasm and can lead to necrosis, sloughing, and potentially gangrene if extravasation into the tissue occurs at the IV site.
9.
d. Prolonged use of procainamide may lead to a positive antinuclear antibody test; if this occurs, the risk–benefit ratio of procainamide use should be reassessed.
10.
a. Epinephrine is administered intramuscularly for the client in anaphylaxis who does not have ventricular fibrillation, pulseless ventricular tachycardia, asystole, or pulseless electrical activity.
PreviousNext
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.